Pharmacological Activity of Scorpion Venom: Updating and Application
Article Sidebar
Main Article Content
Abstract
The study of biomolecules from the components of animals include proteins, enzymes, carbohydrates, peptides, nucleic acids, DNA and RNA have become a hot spot in recent years. Among the venomous animals, venom from scorpions exhibits broad pharmaceutical activities with varieties of targets. Therefore, scorpion venom becomes important and useful for the development of medical and pharmaceutical uses. Recently, drugs based on animal venoms are currently being developed and accepted by the US Food and Drug Administration, such as Captopril (modified teropride from Bothrops jararaca) for the treatment of high blood pressure. Many studies reported that the isolated peptides from scorpion venom showed a variety of bioactivities such as antibacterial, antifungal, antivirus, anti-parasite, anti-cancer, anti-inflammatory and immunomodulation. Therefore, peptides from scorpion venom become a new promising for development of many drugs in the future. The research evidence of pharmaceutical activities of scorpion venom, including its mechanisms have been reviewed and updated for further development to a new drug in the future.
Article Details
References
Abdel-Rahman MA, Quintero-Hernández V, Possani LD. Scorpion Venom Gland Transcriptomics and Proteomics: An Overview. In: Gopalakrishnakone P, Calvete J, eds. Venom Genomics and Proteomics. Toxinology. Dordrecht: Springer, 2016: 105–124.
Ahmadi S, Knerr JM, Argemi L, et al. Scorpion venom: Detriments and benefits. Biomedicines 2020; 8(5): 1–31.
Almaaytah A, Albalas Q. Scorpion venom peptides with no disulfide bridges: A review. Peptides 2014; 51: 35–45.
Amorim FG, Cordeiro FA, Pinheiro-Júnior, et al. Microbial production of toxins from the scorpion venom: properties and applications. Appl Microbiol Biotechnol 2018; 102(15): 6319–6331.
Attarde SS, Pandit SV. Scorpion venom as therapeutic agent - current perspective. Int J Curr Pharm 2016; 7(2): 59–72.
Bernardes-Oliveira E, Farias KJS, Gomes DL, et al. Tityus serrulatus Scorpion Venom Induces Apoptosis in Cervical Cancer Cell Lines. Evid Based Complementary Altern Med 2019; 2019.
Chaubey MK. Scorpion venom: pharmacological analysis and its applications. Eur J Biol Res 2017; 7(4): 271–290.
Corzo G, Escoubas P, Villegas E, et al. Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem J 2001; 359(1): 35–45.
Dai C, Ma Y, Zhao Z, et al. Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother 2008; 52(11): 3967–3972.
Ghosh A, Roy R, Nandi M, et al. Scorpion Venom–Toxins that Aid in Drug Development: A Review. Int J Pept Res Ther 2019; 25(1): 27–37.
Giuliani A, Pirri G, Bozzi A, et al. Antimicrobial peptides: Natural templates for synthetic membrane-active compounds. Cell Mol Life Sci 2008; 65(16): 2450–2460.
González JA, Vallejo JR. The scorpion in Spanish folk medicine: A review of traditional remedies for stings and its use as a therapeutic resource. J Ethnopharmacol 2013; 146(1): 62–74.
Harrison PL, Abdel-Rahman MA, Miller K, et al. Antimicrobial peptides from scorpion venoms. Toxicon 2014; 88: 115–137.
Huang Y, Huang J, Chen Y. Alpha-helical cationic antimicrobial peptides: Relationships of structure and function. Protein Cell 2010; 1(2): 143–152.
Li J, Wang X, Zhang T, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci 2015; 10(2): 81–98.
Li Y, Xiang Q, Zhang Q, et al. Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application. Peptides 2012; 37(2): 207–215.
Ortiz E, Gurrola GB, Schwartz EF, et al. Scorpion venom components as potential candidates for drug development. Toxicon 2015; 93: 125–135.
Papo N, Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 2005; 62(7–8): 784–790.
Rodríguez de la Vega RC, Schwartz EF, Possani LD. Mining on scorpion venom biodiversity. Toxicon 2010; 56(7): 1155–1161.
Stevens M, Peigneur S, Tytgat J. Neurotoxins and their binding areas on voltage-gated sodium channels. Front Pharmacol 2011; 2: 1–13.
Stockmann R. Introduction to Scorpion Biology and Ecology. In: Gopalakrishnakone P, Ferroni Schwartz E, Possani L, Rodríguez de la Vega R, eds. Scorpion Venoms. Dordrecht: Springer, 2013: 1-29.
Tarazi S. Scorpion venom as antimicrobial peptides (AMPs): A review article. Int Arab J of Antimicrob Agents 2015.
Tobassum S, Tahir HM, Arshad M, et al. Nature and applications of scorpion venom: an overview. Toxin Rev 2018; 39(3): 214–225.
Torres-Larios A, Gurrola GB, Zamudio FZ, et al. Hadrurin, A new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur J Biochem 2000; 267(16): 5023–5031.
Uawonggul N, Thammasirirak S, Chaveerach A, et al. Purification and characterization of Heteroscorpine-1 (HS-1) toxin from Heterometrus laoticus scorpion venom. Toxicon 2007; 49(1): 19–29.
Uzair B, Bint-e-Irshad S, Khan, et al. Scorpion Venom Peptides as a Potential Source for Human Drug Candidates. Protein Pept Lett 2018; 25(7): 702–708.
Zargan J, Umar S, Sajad M, et al. Scorpion venom (Odontobuthus doriae) induces apoptosis by depolarization of mitochondria and reduces S-phase population in human breast cancer cells (MCF-7). Toxicol in Vitro 2011; 25(8): 1748–1756.
